HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

almorexant

a dual orexin receptor antagonist for treatment of insomnia
Also Known As:
((2R)-2-((1S)-6,7-dimethoxy-1-(2-(4-trifluoromethylphenyl)-ethyl)-3,4-dihydro-1H-isoquinolin-2-yl)-N-methyl-2-phenylacetamide); ACT-078573
Networked: 36 relevant articles (5 outcomes, 11 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Dingemanse, Jasper: 7 articles (05/2014 - 01/2011)
2. Hoever, Petra: 7 articles (05/2014 - 01/2011)
3. Hoyer, Daniel: 4 articles (12/2013 - 12/2012)
4. Jenck, Francois: 3 articles (04/2015 - 04/2013)
5. Steiner, Michel A: 3 articles (04/2015 - 04/2013)
6. Jacobson, Laura H: 3 articles (12/2013 - 01/2013)
7. Fendt, Markus: 3 articles (10/2013 - 12/2012)
8. Gee, Christine E: 3 articles (10/2013 - 12/2012)
9. Kilduff, Thomas S: 2 articles (10/2020 - 03/2013)
10. Morairty, Stephen R: 2 articles (10/2020 - 03/2013)

Related Diseases

1. Sleep Initiation and Maintenance Disorders (Insomnia)
2. Sleep Wake Disorders
3. Cataplexy
4. Fatigue
5. Sleepiness

Related Drugs and Biologics

1. Orexin Receptor Antagonists
2. Orexins
3. suvorexant
4. Orexin Receptors
5. N- ((1- ((5- (4- fluorophenyl)- 2- methyl- 4- thiazolyl)carbonyl)- 2- piperidinyl)methyl)- 4- benzofurancarboxamide
6. MK-6096
7. lemborexant
8. Ketoconazole (Nizoral)
9. Anti-Anxiety Agents (Anxiolytics)
10. Zolpidem (Ambien)

Related Therapies and Procedures

1. Oral Administration